نتایج جستجو برای: nasal vaccine

تعداد نتایج: 152195  

Journal: :Journal of bacteriology 2008
Bonggoo Park Victor Nizet George Y Liu

Nasal colonization by Staphylococcus aureus is a major predisposing factor for subsequent infection. Recent reports of increased S. aureus colonization among children receiving pneumococcal vaccine implicate Streptococcus pneumoniae as an important competitor for the same niche. Since S. pneumoniae uses H2O2 to kill competing bacteria, we hypothesized that oxidant defense could play a significa...

Journal: :The Journal of veterinary medical science 2008
Mika Ito Makoto Nagai Yuji Hayakawa Hirofumi Komae Naruto Murakami Syouichi Yotsuya Shingo Asakura Yoshihiro Sakoda Hiroshi Kida

In August 2007, an outbreak of equine influenza occurred among vaccinated racehorses with Japanese commercial equine influenza vaccine at Kanazawa Racecourse in Ishikawa prefecture in Japan. Apparent symptoms were pyrexia (38.2-41.0 degrees C) and nasal discharge with or without coughing, although approximately half of the infected horses were subclinical. All horses had been shot with a vaccin...

Journal: :Ear, nose, & throat journal 2021

Post-vaccine olfactory and gustatory disorders are very rare were reported in patients who received influenza vaccines. In this article, we report 6 cases of post-coronavirus disease 2019 (COVID-19) vaccine with negative nasal swabs. Precisely, dysfunctions 5 1 patients, respectively. Sense occurred after the first injection AstraZeneca (n = 4) or second Pfizer 2) 4 cases, disorder was confirme...

Journal: :Infection and immunity 1999
F Oftung L M Naess L M Wetzler G E Korsvold A Aase E A Høiby R Dalseg J Holst T E Michaelsen B Haneberg

We have studied the ability of the Norwegian group B meningococcal outer membrane vesicle (OMV) vaccine, when administered intranasally without adjuvant, to induce T-cell responses in humans. A group of 12 vaccinees was immunized with four doses of OMVs (250 micrograms of protein/dose) at weekly intervals, and a single booster dose was given 5 months later. In vitro T-cell proliferation in resp...

Journal: :Clinical and Vaccine Immunology 2008

Journal: :Journal of clinical microbiology 1977
M J Spencer J D Cherry K R Powell

The "R-75" strain live, attenuated, serum inhibitor-resistant influenza B vaccine was administered intranasally by drops in two doses 14 days apart to 21 volunteers. Each vaccinee was paired with a close associate (roommate or workmate) who similarly received two doses of a placebo solution. Although about 50% of both vaccine and placebo recipients complained of symptoms after dosage, the sever...

Journal: :PLoS ONE 2008
Paul E. Makidon Anna U. Bielinska Shraddha S. Nigavekar Katarzyna W. Janczak Jessica Knowlton Alison J. Scott Nicholas Mank Zhengyi Cao Sivaprakash Rathinavelu Michael R. Beer J. Erby Wilkinson Luz P. Blanco Jeffrey J. Landers James R. Baker

BACKGROUND Hepatitis B virus infection remains an important global health concern despite the availability of safe and effective prophylactic vaccines. Limitations to these vaccines include requirement for refrigeration and three immunizations thereby restricting use in the developing world. A new nasal hepatitis B vaccine composed of recombinant hepatitis B surface antigen (HBsAg) in a novel n...

Journal: :Infection and immunity 2008
Y Koizumi T Kurita-Ochiai S Oguchi M Yamamoto

Porphyromonas gingivalis has been shown to accelerate atherosclerotic lesion development in hyperlipidemic animals. We assessed the potential of a nasal vaccine against P. gingivalis infection for the prevention of atherosclerosis. Apolipoprotein E-deficient spontaneously hyperlipidemic (Apoe(shl)) mice were nasally immunized with the 40-kDa outer membrane protein (OMP) of P. gingivalis plus ch...

Journal: :The Journal of infectious diseases 2005
John A Mikszta Vincent J Sullivan Cheryl Dean Andrea M Waterston Jason B Alarcon John P Dekker John M Brittingham Juan Huang C Robin Hwang Matthew Ferriter Ge Jiang Kevin Mar Kamal U Saikh Bradley G Stiles Chad J Roy Robert G Ulrich Noel G Harvey

A new anthrax vaccine under clinical investigation is based on recombinant Bacillus anthracis protective antigen (rPA). Here, we investigated microneedle-based cutaneous and nasal mucosal delivery of rPA in mice and rabbits. In mice, intradermal (id) delivery achieved up to 90% seroconversion after a single dose, compared with 20% after intramuscular (im) injection. Intranasal (inl) delivery of...

2009
S. MARTIN

The authors studied the immune response of vaccinated and unvaccinated pigs to challenge infection with Aujeszky's disease virus. One group re­ ceived a live vaccine by the nasal route, a second group was inoculated intra­ muscularly with inactivated vaccine, and a third group served as unvaccinated controls. General and local immune responses were measured by indirect ELISA, serum neutralisati...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید